Differences in reported sepsis incidence according to study design: a literature review by Saga Elise Mariansdatter et al.
RESEARCH ARTICLE Open Access
Differences in reported sepsis incidence
according to study design: a literature
review
Saga Elise Mariansdatter*†, Andreas Halgreen Eiset†, Kirstine Kobberøe Søgaard and Christian Fynbo Christiansen
Abstract
Background: Sepsis and severe sepsis are common conditions in hospital settings, and are associated with high rates
of morbidity and mortality, but reported incidences vary considerably. In this literature review, we describe the
variation in reported population-based incidences of sepsis and severe sepsis. We also examine methodological and
demographic differences between studies that may explain this variation.
Methods: We carried out a literature review searching three major databases and reference lists of relevant articles,
to identify all original studies reporting the incidence of sepsis or severe sepsis in the general population. Two authors
independently assessed all articles, and the final decision to exclude an article was reached by consensus. We extracted
data according to predetermined variables, including study country, sepsis definition, and data source. We then calculated
descriptive statistics for the reported incidences of sepsis and severe sepsis. The studies were classified according to the
method used to identify cases of sepsis or severe sepsis: chart-based (i.e. review of patient charts) or code-based
(i.e. predetermined International Classification of Diseases [ICD] codes).
Results: Among 482 articles initially screened, we identified 23 primary publications reporting incidence of sepsis
and/or severe sepsis in the general population. The reported incidences ranged from 74 to 1180 per 100,000
person-years and 3 to 1074 per 100,000 person-years for sepsis and severe sepsis, respectively. Most chart-based
studies used the Bone criteria (or a modification hereof) and Protein C Worldwide Evaluation in Severe Sepsis
(PROWESS) study criteria to identify cases of sepsis and severe sepsis. Most code-based studies used ICD-9 codes,
but the number of codes used ranged from 1 to more than 1200. We found that the incidence varied according
to how sepsis was identified (chart-based vs. code-based), calendar year, data source, and world region.
Conclusion: The reported incidences of sepsis and severe sepsis in the general population varied greatly between
studies. Such differences may be attributable to differences in the methods used to collect the data, the study period,
or the world region where the study was undertaken. This finding highlights the importance of standardised
definitions and acquisition of data regarding sepsis and severe sepsis.
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Background
Sepsis is associated with high rates of morbidity and
mortality, accounting for as much as one of every two to
three in-hospital deaths [1]. Notably, the mortality rates
of sepsis increased during the last decade, which is in
contrast to the declining rates of all other major causes
of death in the US [2].
Determining the incidence of sepsis is of great interest
to both clinicians and public health officials, in order to
quantify the burden of the disease [3]. However, estima-
tion of sepsis incidence is difficult, as it depends on the
definition of sepsis, the method used to assess the condi-
tion, and the underlying population. Until 1992, no con-
sensus existed on the terminology used to describe the
presence and severity of sepsis, impairing comparison of
studies on sepsis incidence and therapy outcomes [4].
The 1991 American College of Chest Physicians/Society
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of Critical Care Medicine (ACCP/SCCM) Consensus
Conference addressed this issue, with the aim to create a
set of criteria for identifying and assessing the severity of
sepsis [5]. The consensus proposal included an introduc-
tion of the systemic inflammatory response syndrome
(SIRS) criteria for early identification of sepsis, defining
sepsis as 2 SIRS criteria in patients with known or sus-
pected infection, and severe sepsis as sepsis associated
with organ dysfunction, hypoperfusion, or hypotension
(Table 1). Though repeatedly criticised for being too sen-
sitive [6, 7] and of questionable prognostic value [8–10]
these easily applied “Bone criteria” remained the clinical
standard in many hospital guidelines even after the intro-
duction of internationally agreed-upon, but more compre-
hensive, criteria [6, 11, 12]. In 2016 the definition of sepsis
was updated to categorise sepsis as a life-threatening
organ dysfunction caused by a dysregulated host response
to infection (by The Third International Consensus Defi-
nitions for Sepsis and Septic Shock) [13].
In this review, we focus on the variation in reported in-
cidences of sepsis and severe sepsis in the general popula-
tion, and discuss the potential explanations including the
use of different definitions or methods to assess sepsis.
Methods
Literature search and study selection
We included original studies with incidences of sepsis or
severe sepsis in the general population (in person-years)
as an outcome, published before 2016. Consequently, we
excluded studies focusing on a specific subgroup of
patients (e.g. neonatal sepsis, sepsis caused by a spe-
cific microbial agent), as these studies would include
only a fraction of the general population as their study
population. The number of excluded studies and reasons
for exclusion are described in Fig. 1.
We searched PubMed (search string (((“Sepsis/epidemi-
ology” [Mesh]) AND (“sepsis” [Title] OR “septicaemia”
[Title])) AND “incidence” [Title/Abstract]) AND “english”
[Language]), EMBASE (search string ‘sepsis’/exp OR ‘sepsis’
AND (‘epidemiology’/exp OR ‘epidemiology’ OR ‘incidence’/
exp OR ‘incidence’) AND [english]/lim) and Cochrane Li-
brary (search string #1: MeSH descriptor: [Sepsis] explode
all trees and with qualifier(s): [Epidemiology – EP] + #2:
(“sepsis”:ti or “septicaemia:ti”) + #3: ”incidence”:ti,ab).
The title and abstract of the resulting articles were
screened and categorised according to predefined criteria
if excluded (see section Availability of data and mate-
rials). All included articles – along with additional articles
found in reference lists – were retrieved, read in full and
excluded according to the same criteria (see Fig. 1). Two
authors (SEM and AHE) performed all rounds independ-
ently; the final decision to exclude an article was reached
by consensus.
Data were extracted from each study according to a
predetermined list of variables (see section Availabil-
ity of data and materials). If a study reported several
incidences – e.g. for different years or applying different
methodologies – each incidence measure was registered
as an observation. We adapted a widely used terminology
to categorise the studies according to method used to
identify sepsis or severe sepsis: 1. “chart-based” including
studies that identified patients by review of patient charts
and 2. “code-based” including studies that identified
patients using diagnostic codes [3, 14–16]. To examine
regional differences in incidence of sepsis and severe
sepsis each study was categorised according to World
Bank region [17].
Data management and descriptive statistics were per-
formed using R [18]. In order to examine the heterogen-
eity that gives rise to the differences in incidence as well
as possible interactions, we produced a number of box-
plots based on crude data to allow for a visual evaluation
of some of the factors that influence the reported inci-
dence. Further, we present detailed tables that allow the
reader to compare the included studies. The data set,
along with the R-code and codebook, are freely available
(see section Availability of data and materials).
International Classification of Diseases (ICD)
In the code-based studies, ICD codes were used to identify
cases from discharge databases without specific informa-
tion on physiological parameters. Implementation of the
tenth revision of the ICD coding system (ICD-10) started
in 1994 [19], but actual implementation dates vary among
countries and was finally completed in the US as of
October 1, 2015 [20]. Consequently, ICD-10 data was
used in only two studies [21, 22]. A table with the full
lists of specific sepsis codes in the ICD-9 and ICD-10
coding systems are provided as an additional file (see
Additional file 1).
Below is a brief summary of the development of the
guidelines used; Table 1 offers a detailed comparison of
sepsis, severe sepsis, septic shock and multiple organ
dysfunction syndrome.
The 1991 ACCP/SCCM Consensus Conference guidelines
In 1992 Bone et al. proposed a standardised definition of
sepsis [5]. This included an introduction of the four
SIRS criteria: 1. Temperature >38 °C or <36 °C; 2. heart
rate >90 beats per minute; 3. respiratory rate >20 breaths
per minute or PaCO2 < 32 mmHg; and 4. white blood
cell count >12,000/cu mm, <4,000/cu mm, or >10 % im-
mature (band) forms. According to this, systemic inflam-
matory response syndrome (SIRS) was defined as at least
two SIRS criteria, and sepsis was defined as (suspected)
infection and at least two SIRS criteria. In addition it
was suggested that use of the term “septicaemia” should
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Table 1 Criteria proposed to define sepsis and severe sepsis; comparison of guidelines
Sepsis definition Bone et al., 1992 (Sepsis-1) Levy et al., 2003 (Sepsis-2) Dellinger et al., 2013 Singer et al., 2016 (Sepsis-3)
Infection, documented or suspected, and at least 2
of the following (SIRS criteria):
Infection, documented or suspected, and some of the following: Suspected or documented infection
and an acute increase of ≥2 SOFA











Heart rate >90 bpm >90 bpm or >2 SD above the normal value for age –











– >20 mL/kg over 24 hrs –
Hyperglycemia in the
absence of diabetes
– Plasma glucose >120
mg/dL
or >7.7 mM/L














Normal white blood cell count with >10% immature forms
–
Plasma C reactive protein – >2 SD above the normal value –
Plasma procalcitonin – >2 SD above the normal value –
Hemodynamic
parameters











MAP < 70 mm/Hg 1
dop ≤ 5 or dob (any
dose)
2
dop > 5 or epi ≤ 0.1
or nor ≤ 0.1
3
dop > 15 or epi > 0.1
















Table 1 Criteria proposed to define sepsis and severe sepsis; comparison of guidelines (Continued)
Mixed venous oxygen
saturation
– >70% – –















Acute oliguria – Urine output <0.5 mL/
kg/hr or 45 mmol/L for
at least 2 hrs
Urine output <0.5 mL/kg/hr for at











> 5.0 [> 440] (or <
200 mL/d)
4
Creatinine increase – >0.5 mg/dL >0.5 mg/dL or 44.2 μmol/L
Coagulation abnormalities – INR >1.5 or aPTT >60 s –
Ileus – Absent bowel sounds –






Hyperbilirubinemia – Plasma total bilirubin >4 mg/dL or 70 mmol/L Bilirubin (mg/dl)
[μmol/L]:
SOFA score:
1.2–1.9 [> 20-32] 1
2.0–5.9 [33-101] 2
6.0–11.9 [102-204] 3
> 12.0 [> 204] 4
Tissue perfusion
parameters















Table 1 Criteria proposed to define sepsis and severe sepsis; comparison of guidelines (Continued)
Capillary refill – Decreased capillary refill or mottling –
Severe sepsis definition Bone et al., 1992 Dellinger et al., 2013 Singer et al., 2016




induced), in the absence
of other causes
Systolic blood pressure < 90 mmHg
or
A reduction of ≥ 40 mmHg from baseline.
As defined for sepsis –
Lactate Lactic acidosis Lactate above upper limit of laboratory normal –
Organ
failure
Kidney injury Oliguria As defined for sepsis
but
Creatinine > 2 mg/dL (176.8 μmol/L)
–
Acute lung injury – Pneumonia not the infectious source: PaO2/FIO2 < 250
or
Pneumonia the infectious source: PaO2/FIO2 < 200
–
Liver injury – As defined for sepsis
but
Bilirubin > 2 mg/dL (34.2 μmol/L)
–
Mental status Acute alteration As defined for sepsis –
Septic shock Hypotension despite adequate fluid resuscitation
along with the presence of perfusion
abnormalities, as listed above.
Hypotension not reversed with fluid resuscitation. Sepsis with persisting hypotension
requiring vasopressors to maintain
MAP ≥65 mmHg and having a
serum lactate level >2 mmol/L
(18mg/dL) despite adequate
volume resuscitation.
Multiple organ dysfunction syndrome (MODS) Altered organ dysfunction in an acutely ill patient

















be avoided. We will refer to this definition as the “Bone
criteria”.
International Sepsis Definitions Conference modifications
In 2003, the first Surviving Sepsis Campaign was pub-
lished [6]. In an effort to increase the clinical utility, the
diagnostic criteria were expanded to include other parame-
ters, among these inflammatory, hemodynamic and tissue
perfusion. It was emphasised that none of these new cri-
teria were specific for sepsis. The latest campaign edition
published in 2012 contained only minor revisions, and thus
these expanded criteria have remained the recommended
clinical standard [3]. However, a revised international
definition of sepsis criteria has recently been published
[13], in which the SIRS criteria are replaced by the sepsis-
related organ failure assessment (SOFA) score [23].
Fig. 1 Flow chart of study selection
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Results
Our search identified 467 articles of which 430 were
excluded after screening (see Fig. 1). An additional 12
articles were identified from the reference lists of the
included articles, of which five were excluded after going
through the abstracts. Of 44 articles read in full 21 were
excluded: 10 articles did not provide sepsis or severe sepsis
incidence on a person-year basis [15, 24–32], eight articles
did not report sepsis or severe sepsis incidence as an out-
come [33–40], two articles reported sepsis or severe sepsis
incidence for a subgroup of patients [41, 42] and one
article did not use a relevant design to compute sepsis
and severe sepsis incidences [43]. Thus, we included a
total of 23 articles: 11 chart-based and 12 code-based
studies. Summaries of the included studies can be found
in Tables 2 and 3.
Chart-based studies
Nine studies [44–52] screened patients according to
pre-defined criteria for sepsis and/or severe sepsis; two
studies [53, 54] analysed previously collected data. One
chart-based study on severe sepsis reported incidences
for several years. Most chart-based studies used the Bone
criteria (or a modification hereof) and Protein C Worldwide
Evaluation in Severe Sepsis (PROWESS) study criteria to
identify cases of sepsis and severe sepsis (Table 2). For organ
dysfunction definitions, adaptations of the PROWESS study
criteria [55] were the most frequently used (see Additional
file 2 for a detailed description).
Code-based studies
Three code-based studies applied different algorithms to
the same data set [16, 22, 56] while three and six code-
based studies reported several years' observations of sep-
sis and severe sepsis incidences, respectively [22, 56–63]
(Table 3).
Most code-based studies used ICD-9, though there was
great diversity in what and how many codes were used,
ranging from 1 to more than 1200 (see Additional file 3).
Three code-based studies used the Bone criteria for
validation: Angus et al. and Shen et al. [14, 56] used the
combination of ICD codes defined in their methods ap-
plied to an alternate cohort and a randomly selected
database sample, respectively, while Martin et al. [63]
compared only the ICD-9 codes specific for septicaemia
to a chart-based method. In general, there was a high
degree of agreement between patients identified using
ICD codes and patients identified by the Bone criteria,
respectively. However, Angus et al. did find that their
ICD codes generated higher incidences than what was
found for the reference cohort using clinical and physio-
logic data [14].
Sepsis and severe sepsis incidence in the general population
Overall, we found great variation in incidence both
between and across methods used to identify sepsis and
severe sepsis, ranging from 74 to 1180 per 100,000
person-years and 3 to 1074 per 100,000 person-years,
respectively. The incidence of both sepsis and severe
sepsis increased over time (Fig. 2). When stratifying on
method used to identify sepsis, we found that chart-
based studies in general reported a higher incidence of
sepsis than the code-based studies, whereas the opposite
was the case for severe sepsis. There was a great diversity
in the data source used: studies including patients from all
wards in the hospital (”Hospital wide”) found the highest
sepsis incidence whereas studies only including patients
from intensive care units (ICUs) found a relatively low
severe sepsis incidence (see Additional files 4 and 5).
Stratifying on World Bank region, we found the lowest
sepsis incidence in North America and the lowest severe
sepsis incidence in the Europe & Central Asia region; in
both cases the incidence was highest in the East Asia &
Pacific region (Fig. 3). In addition, we examined for inter-
action between calendar year, World Bank region and
method (plots not shown). While we did find interaction
with calendar year for both World Bank region and chart/
code based studies, there was a consistent trend in the rise
of incidence. The interaction of method and World Bank
region can be seen in Fig. 3.
Discussion
In this literature review, we found that the reported in-
cidence of sepsis and severe sepsis in the general popu-
lation varied greatly between the included studies. We
compared the methods used and the demographic char-
acteristics of the studied populations. We found that the
variation may in part be attributable to whether a chart-
based or a code-based method was used, differences in the
criteria used for identifying cases of sepsis or severe sepsis
within these groups, year of incidence measure, and the
World Bank region in which the study was conducted.
In most chart-based studies on severe sepsis incidence,
cases were identified in ICUs only. Such selection might
introduce bias towards a lower incidence because patients
that fulfil the criteria for severe sepsis but did not need
ICU care were excluded. Indeed, these studies did on aver-
age find a lower incidence of severe sepsis than studies
with other inclusion criteria. However, the chart-based
study by Karlsson et al. [50] included admissions to both
ICUs and other hospital wards, and still found an inci-
dence of severe sepsis in adults much lower than what
was found within a similar time period in the code-based
studies of Dombrovskiy et al. [60] and Kumar et al. [62].
This indicates that other factors play an important role for
the observed differences in incidence between chart- and
code-based studies, and the question is whether these very
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Table 2 Chart-based studies of sepsis and severe sepsis incidence in the general population














Nygard, 2014 [51] Henriksen,
2015 [49]


















11 ICUs 3 ICUs 1 hospital 3 ICUs 1 ED
Study
population




NA/15,362 NA/691 NA/621 NA/92,672 702/199 NA/472 NA/246 NA/115 1,191/272 NA/220 621/1,071
Study duration 1995–2000 3 months 2 weeks 10 year 4 months 4 months
/4 days
6 months 1 year 1 year 1 year 1 year
Exclusion criteria <16 years, readmissions,
sepsis not present within
24 h from admission
<15 years <16 years, readmissions,
sepsis not present within










< 15 years < 15 years, severe
sepsis not present












PROWESS Bone criteria Bone criteria PROWESS Bone
criteria





























51 77 95 46; 66 104 38 25 48 130 50 457
Characteristics of chart based studies of sepsis and severe sepsis incidence extrapolated to the general population. i) If study is conducted in two consecutive calendar years the last year is reported. ii) If full data were
not available for 1997, the closest full year’s data were used. Abbreviations: −, not calculated; ED emergency department, hrs hours, ICU intensive care unit, MODS multiple organ dysfunction syndrome, NA not available,






































Country/Region USA USA (7
states)
USA Norway New Jersey,
USA
USA USA Taiwan Sweden USA USA Taiwan
Coding system ICD-9 ICD-9 ICD-9 ICD-10 ICD-9 ICD-9 ICD-9 ICD-9 ICD-9/10vi ICD-9 ICD9 ICD9
Data source NHDS Constructed
database
NHDS NPR New Jersey
SID
NHDS NIS NHIRD SHDR NIS NIS NHIRD
Study population NA 6,621,559 NA 700,107 7,364,550 NA NA 201,657iv
200,000v
2,024,793 NA NA NA
Number of cases
(sepsis/severe sepsis)







NA NA NA/40,856 -
116,749
Exclusion criteria <1 year Neonate
sepsis





<18 years <18 years
Internal validation No Yes Yes No No (Yes)ii No Yes No No No No
Calendar year 1979;
1987

















Characteristics of code based studies of sepsis and severe sepsis incidence extrapolated to the general population. i) Age-standardized to fit the population distribution in the 2000 U.S. consensus. ii) Method validated
by Martin et al. iii) Age-standardized using 2000 world population reported by WHO as standard. iv) No exclusion criteria. v) Exclusion criteria as stated. vi) Discharge diagnoses were classified according to ICD-9 until
the end of 1996. These were translated into ICD-10 for the methods of Angus et al. and Martin et al. vii) Using the method proposed in Angus et al., Flaaten et al. (time of incidence measure: 1997; 2005) and Martin
et al., respectively. viii) Using the method proposed in Angus et al. and Dombrovskiy et al., respectively. Abbreviations: −, not calculated; SHDR Swedish hospital discharge register, NA not available, NHDS national















different approaches are even comparable. Wilhelms et al.
[22] addressed this by applying the methods of Angus
et al., Flaatten, and Martin et al. [14, 21, 63] to the same
database. Notably, Wilhelms found that the methods
identified very different patient cohorts with little overlap,
questioning whether the ICD codes correspond to the
clinical definition of severe sepsis. As mentioned previ-
ously, Angus et al. did indeed find that their criteria
generated higher incidences than the Bone criteria, but
most of the code-based studies did not explore the clinical
characteristics of identified cases, even though many codes
not specific for sepsis were used. In a US study by Gaieski
et al. [15], the methods of Angus et al., Wang et al.,
Dombrovskiy et al., and Martin et al. [2, 14, 59, 63], were
all applied to a cohort identified using the Nationwide In-




































Angus et al., 2001
Blanco et al., 2008
Brun et al., 2004
CDC et al., 1990
Chen et al., 2013
Davis et al., 2011
Dombrovskiy et al., 2005
Dombrovskiy et al., 2007
Esper et al., 2006
Esteban et al., 2007
Finfer et al., 2004
Flaatten et al., 2004
Harrison et al., 2006
Henriksen et al., 2015
Karlsson et al., 2007
Kumar et al., 2011
Lagu et al., 2012a
Lagu et al., 2012b
Martin et al., 2003
Nygard et al., 2014
Padkin et al., 2003
Shen et al., 2010a
Shen et al., 2010b
Vesteinsdottir et al., 2011
Wilhelms et al., 2010a
Wilhelms et al., 2010b
Wilhelms et al., 2010c






























Fig. 3 Boxplot of the incidence of sepsis and severe sepsis stratified on World Bank region. The figure gives a crude estimate of the median, the
interquartile range (IQR), and the highest and lowest value within 1.5 × IQR. Data beyond the end of the whiskers are plotted as black points.
Points represent single observations that contribute data to the estimate; colours indicate whether the study is chart- or code-based
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some of the included code-based studies [16, 59, 62]. The
incidences found using each of these methods were com-
pared to the incidence found using the specific ICD-9 sep-
sis codes only. Apart from finding that these methods led
to very different estimates of severe sepsis, the authors
also found that only between 14 % (Wang, Angus) and
48 % (Dombrovskiy) of severe sepsis cases had been
assigned the ICD-9 severe sepsis code (995.92).
The increase found in both sepsis and severe sepsis in-
cidence over the years could be due to an actual increase
caused by factors such as increasing prevalences of co-
morbidities in the general population, a change in the
population demographics with more elderly, use of intra-
venous accesses or other predisposing factors for sepsis.
However, an increased clinical and political awareness of
sepsis, as pursued by the Surviving Sepsis campaigns, or
perhaps a change in coding practice could also lead to
higher estimates [64]. Probably, the increase in reported
incidences is caused by a combination of several or all of
these. As recently suggested, an automatic epidemiological
surveillance system based on electronic health records for
patients with sepsis, may give better estimates for both
sepsis incidence and mortality [65].
When stratifying on World Bank region, we found a
variation in incidences of both sepsis and severe sepsis.
Remarkably, the incidence of sepsis was generally lower
in the North America region compared to Europe &
Central Asia, whereas the opposite was the case for se-
vere sepsis. These differences may arise from differences
in coding practice and the related economic incentive,
and access to hospital and ICU care. The study by
Wilhelms et al. [22] supports this observation: When
reproducing the studies by Angus et al. [14] and Martin
et al. [63] on a Swedish cohort they find remarkably lower
incidences than was reported for the studies set in North
America.
The relatively low number of studies on sepsis and
severe sepsis incidence after stratifying on code-based
or chart-based studies limits our review. Also, the great
heterogeneity of the included studies, such as the number
and type of codes used to define sepsis and severe sepsis
in the code-based studies, may not only give rise to major
differences in outcome but also impedes direct com-
parison, as the studies differs from each other by several
variables.
The importance of reaching a greater consistency in
the definition of sepsis and severe sepsis used in epi-
demiological studies has been commented by Singer et al.
[13], following the third international sepsis definition
consensus conference, and recommendations are given
for both clinical identification of sepsis as well as ICD
coding. If these recommendations are successfully im-
plemented worldwide, this may offer a more simple and
intuitive approach to diagnosis of sepsis and septic
shock. This approach, together with the proposed rec-
ommendations for registration of the condition, may
not only lead to a more prompt recognition of sepsis,
but also enable a higher consistency for epidemiological
studies reporting sepsis incidence.
Conclusion
The reported incidence of sepsis and severe sepsis in the
general population varies greatly between studies. In this
literature review, we present a detailed systematic exam-
ination of all original studies reporting the incidence of
sepsis or severe sepsis in the general population as a main
outcome. We find that the methods used differ between
the studies to a degree that greatly hampers the inference
about any variable's impact on the incidence. This high-
lights the importance of standardised definitions and
acquisition of data regarding sepsis and severe sepsis.
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